Exclusion of the left atrial appendage to reduce thromboembolic risk related to atrial
fibrillation was first performed surgically in 1949. Over the past 2 decades, the field of …

Background: As the use of left atrial appendage closure (LAAC) becomes more widespread,
improvements in resource utilization and cost-effectiveness are necessary. Currently, there …

With recent advancements in imaging modalities and techniques and increased recognition
of the long-term impact of several structural heart disease interventions, the number of …

Background The effects of left atrial appendage (LAA) occlusion compared to non-vitamin K
antagonist oral anticoagulant (NOAC) therapy in patients with atrial fibrillation (AF) remain …

Aims To evaluate factors influencing the length of stay in patients undergoing percutaneous
left atrial appendage occlusion (LAAO). Methods and results Patient characteristics …

Transcatheter left atrial appendage closure (LAAC) is now established as an effective
technique for stroke prevention in select patients with nonvalvular atrial fibrillation (AF) and …

Background: Left atrial appendage occlusion (LAAO) is a safe and effective alternative to
oral anticoagulation for thromboprophylaxis in patients with nonvalvular atrial fibrillation …

Background Left atrial appendage occlusion (LAAO) with WATCHMAN currently requires
preprocedural imaging, general anesthesia, and inpatient overnight admission. We sought …

Kodade virvendusarütmiaga (KVA) seotud trombembooliliste tüsistuste ennetamise
kuldstandard on tänapäeval suukaudne antikoagulantravi otsese toimega suukaudsete …

AF is associated with an increased risk of thromboembolic events, which is usually managed
with oral anticoagulation therapy. However, despite a broad range of anticoagulant options …